Share

|

|

|

>

  • Showcases
  • >
  • Impower010 trial update confirms adjuvant atezolizumab efficacy for patients with high PD-L1 expression

Impower010 trial update confirms adjuvant atezolizumab efficacy for patients with high PD-L1 expression

Nasser Altorki talks through the high PD-L1 expression sub-analysis findings from the IMpower010 trial of adjuvant atezolizumab versus best supportive care for stage II–IIIA NSCLC (5:37).

Don’t fall behind!

Get the latest headlines – in your specialties of choice – delivered straight to your inbox.

Showcase

MEET THE SENIOR TEAM

Lucy Piper

medwireNews Bureau Chief

Related Showcases

|